Wolverine Asset Management’s Cardio Diagnostics CDIO Stock Holding History

Wolverine Asset Management’s Portfolio CDIO Stock Details CDIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$203	Hold	104	–	–	﹤0.01%	1643
2025 Q4	$282	Hold	104	–	–	﹤0.01%	1609
2025 Q3	$417	Hold	104	–	–	﹤0.01%	1546
2025 Q2	$374	Sell	104 -1	-1%	-$7	﹤0.01%	1547
2025 Q1	$1.04K	Sell	105 -21	-17%	-$327	﹤0.01%	1456
2024 Q4	$3.46K	Hold	126	–	–	﹤0.01%	1444
2024 Q3	$842	Hold	126	–	–	﹤0.01%	1538
2024 Q2	$2.08K	Hold	126	–	–	﹤0.01%	1491
2024 Q1	$5.36K	Buy	126 +7	+6%	+$399	﹤0.01%	1382
2023 Q4	$8.9K	Sell	119 -41	-26%	-$1.42K	﹤0.01%	1397
2023 Q3	$1.63K	Hold	160	–	–	﹤0.01%	1662
2023 Q2	$5.7K	Buy	160 +109	+214%	+$6.15K	﹤0.01%	1460
2023 Q1	$6.01K	Buy	+51	New	+$4.02K	﹤0.01%	1519
2022 Q4	–	Sell	-7,132	Closed	-$2.15M	–	2141
2022 Q3	$2.15M	Sell	7,132 -2,155	-23%	-$647K	0.02%	545
2022 Q2	$2.77M	Buy	9,287 +676	+8%	+$201K	0.03%	459
2022 Q1	$2.55M	Buy	+8,611	New	+$2.55M	0.02%	445

Other funds holding CDIO

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wolverine Asset Management's CDIO Position: Q1 2026 in Review

Wolverine Asset Management held its Cardio Diagnostics (CDIO) position steady in Q1 2026 at 104 shares worth $203. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

Wolverine Asset Management first reported a position in CDIO in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.77M in Q2 2022. 16 funds tracked by Wall St. Rank hold CDIO as of Q1 2026.

Wolverine Asset Management held 104 shares of Cardio Diagnostics worth $203 as of Q1 2026.
Wolverine Asset Management left its Cardio Diagnostics share count unchanged in Q1 2026.
Cardio Diagnostics made up ﹤0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #1643 holding.
Wolverine Asset Management first reported a position in Cardio Diagnostics in Q1 2022 and has held it in 16 quarters since.
Wolverine Asset Management's Cardio Diagnostics position peaked at $2.77M in Q2 2022.
16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.